General Oriental
2
75M
2
- Stages of investment
- Areas of investment
Summary
The main office of represented Corporate Investor is situated in the Geneva. The venture was found in Europe in Switzerland.
The fund is constantly included in less than 2 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2018.
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the General Oriental, startups are often financed by Carebridge Holdings, Apricot Capital. The meaningful sponsors for the fund in investment in the same round are Trustbridge Partners, GP Healthcare Capital.
For fund there is no match between the location of its establishment and the land of its numerous investments - China. Among the most successful fund investment fields, there is Biotechnology. Among the most popular portfolio startups of the fund, we may highlight GenomiCare Biotechnology. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Investments by industry
- Biotechnology (1)
- Software (1)
- Analytics (1)
- Business Information Systems (1)
- Business Intelligence (1) Show 1 more
- Investments by region
-
- Netherlands (1)
- China (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 390M
- Group Appearance index
- 1.00
- Strategy success index
- 0.83
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| GenomiCare Biotechnology | 18 Dec 2018 | Biotechnology | Early Stage Venture | 30M | China, Shanghai |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.